Cargando…
A case of meropenem-induced liver injury and jaundice
This report describes what we believe is the first reported case of clinically significant cholestasis and acute liver injury within three days of meropenem therapy. An 83-year-old Hispanic female was admitted for sepsis of unknown origin and was started on intravenous meropenem. Three days followin...
Autores principales: | Cheung, Szeya, Bulovic, Jennifer, Pillai, Ajish, Manoj, Trehan, Neeraj, Katriyar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850334/ https://www.ncbi.nlm.nih.gov/pubmed/33552438 http://dx.doi.org/10.1080/20009666.2020.1845929 |
Ejemplares similares
-
Kwashiorkor on the south shore
por: Arcieri, Samuel T., et al.
Publicado: (2021) -
Drug-Induced Liver Injury After Soy Protein Supplement Use
por: Pillai, Ajish, et al.
Publicado: (2015) -
Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection
por: Cheung, Szeya, et al.
Publicado: (2020) -
Favipiravir/meropenem/vancomycin: Cholestatic liver injury following off-label use: case report
Publicado: (2021) -
Meropenem-induced thrombocytopenia: a paediatric case
por: Cachia, Joanna, et al.
Publicado: (2021)